AZD9291 (Osimertinib) With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04181060 |
Recruitment Status :
Recruiting
First Posted : November 29, 2019
Last Update Posted : February 21, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Advanced Lung Non-Squamous Non-Small Cell Carcinoma Metastatic Lung Non-Squamous Non-Small Cell Carcinoma Recurrent Lung Non-Squamous Non-Small Cell Carcinoma Stage IIIB Lung Cancer AJCC v8 Stage IV Lung Cancer AJCC v8 Stage IVA Lung Cancer AJCC v8 Stage IVB Lung Cancer AJCC v8 | Biological: Bevacizumab Drug: Osimertinib | Phase 3 |
PRIMARY OBJECTIVE:
I. To evaluate progression-free survival (PFS) of AZD9291 (osimertinib) and bevacizumab versus AZD9291 (osimertinib) alone as first-line treatment for patients with metastatic EGFR-mutant lung cancers.
SECONDARY OBJECTIVES:
I. To evaluate overall survival (OS). II. To evaluate best objective response rate and duration of objective response.
III. To evaluate time to central nervous system (CNS) progression and CNS PFS. IV. To evaluate toxicity of the combination regimen.
CORRELATIVE OBJECTIVES:
I. To characterize mechanisms of resistance to AZD9291 (osimertinib) and AZD9291 (osimertinib) with bevacizumab first-line therapy through post-progression circulating tumor-derived deoxyribonucleic acid (ctDNA).
II. To assess for ctDNA clearance on study treatment and associate ctDNA clearance with clinical outcomes.
OUTLINE: Patients are randomized to 1 of 2 arms.
ARM A: Patients receive osimertinib orally (PO) once daily (QD) on days 1-21. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity.
ARM B: Patients receive osimertinib PO QD on days 1-21 and bevacizumab intravenously (IV) over 30-90 minutes on day 1. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity.
After completion of study treatment, patients are followed up every 3 months for 10 years.
Study Type : | Interventional (Clinical Trial) |
Estimated Enrollment : | 300 participants |
Allocation: | Randomized |
Intervention Model: | Parallel Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Treatment |
Official Title: | Randomized Phase III Study of Combination AZD9291 (Osimertinib) and Bevacizumab Versus AZD9291 (Osimertinib) Alone as First-Line Treatment for Patients With Metastatic EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) |
Actual Study Start Date : | October 22, 2020 |
Estimated Primary Completion Date : | September 1, 2025 |
Estimated Study Completion Date : | September 1, 2025 |

Arm | Intervention/treatment |
---|---|
Active Comparator: Arm A (osimertinib)
Patients receive osimertinib PO QD on days 1-21. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity.
|
Drug: Osimertinib
Given PO
Other Names:
|
Experimental: Arm B (osimertinib, bevacizumab)
Patients receive osimertinib PO QD on days 1-21 and bevacizumab IV over 30-90 minutes on day 1. Cycles repeat every 21 days in the absence of disease progression or unacceptable toxicity.
|
Biological: Bevacizumab
Given IV
Other Names:
Drug: Osimertinib Given PO
Other Names:
|
- Progression-free survival (PFS) [ Time Frame: From randomization to documented disease progression per Response Evaluation Criteria in Solid Tumors (RECIST) 1.1 or death from any cause, whichever occurs first, assessed up to 10 years ]Will be estimated using the Kaplan-Meier method, and Cox proportional hazards models will be used to estimate the treatment hazard ratios. PFS will use a logrank test stratified on the randomization stratification factors with a one-sided type I error rate of 2.5%.
- Overall survival (OS) [ Time Frame: From randomization to death from any cause, assessed up to 10 years ]Will be estimated using the Kaplan-Meier method, and Cox proportional hazards models will be used to estimate the treatment hazard ratios. OS will be tested at the one-sided 10% level.
- Best objective response rate [ Time Frame: Up to 10 years ]Best objective response will be evaluated via RECIST 1.1 criteria. Will be compared using Fisher's exact tests with a one-sided type I error rate of 2.5%; multivariable logistic regression modeling will be used to adjust for the effect of any covariates that are associated with these categorical outcomes.
- Time to central nervous system progression [ Time Frame: From study randomization to evidence of central nervous system progressive disease, with death and progression as competing events, assessed up to 10 years ]Will be estimated using competing risks methodology, adjusting for death and progression as competing events. Regular central nervous system imaging will occur when patients are on treatment. After they discontinue study treatment, central nervous system imaging will be symptom-prompted during follow up.
- Central nervous system progression-free survival [ Time Frame: From study randomization to evidence of central nervous system progressive disease or death from any cause, whichever occurs first, assessed up to 10 years ]Will be estimated using the Kaplan-Meier method.
- Incidence of adverse events [ Time Frame: Up to 30 days after the last administration of investigational agent ]Toxicity will be determined using the Common Terminology Criteria for Adverse Events (CTCAE). Will be compared using Fisher's exact tests with a one-sided type I error rate of 2.5%; multivariable logistic regression modeling will be used to adjust for the effect of any covariates that are associated with these categorical outcomes.
- Mechanisms of resistance to AZD9291 (osimertinib) and AZD9291 (osimertinib) with bevacizumab first-line therapy through post-progression circulating tumor-derived deoxyribonucleic acid (ctDNA) [ Time Frame: Up to 10 years ]Preliminary analyses of these data will utilize tests for association comparing the frequency of a particular genomic aberration at baseline and at progression (for example, using McNemar's test) and association between alterations and baseline characteristics (for example, using Fisher's exact test). More sophisticated analyses may include multivariable logistic regression modeling and/or competing risks analysis.
- ctDNA clearance on study treatment [ Time Frame: Up to 10 years ]Will assess ctDNA clearance on study treatment and associate ctDNA clearance with clinical outcomes. Cox regression analysis will be used to assess whether EGFR ctDNA clearance is an independent predictor for PFS (and OS), adjusted by treatment effect, the presence of brain metastasis (yes versus [vs.] no), EGFR exon 19 deletion/L858R vs other, Eastern Cooperative Oncology Group (ECOG) performance status (0-1 vs 2) and other possible clinical and biological risk factors.

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patient must have a pathologically-confirmed diagnosis of non-squamous, non-small cell lung cancer (NSCLC)
- Patient must have advanced disease, defined as - either stage IV disease, stage IIIB disease not amenable to definitive multi-modality therapy, or recurrent disease after a prior diagnosis of stage I-III disease. All staging is via the American Joint Committee on Cancer (AJCC)/International Association for the Study of Lung Cancer (IASLC) 8th edition staging criteria
- Patient must have somatic activating sensitizing mutation in EGFR (e.g. but not limited to Exon 19 deletion, L858R, G709X, G719X, exon 19 insertions, L861Q, S768I). Patients with non-sensitizing mutations in EGFR (EGFR exon 20 insertions) are not eligible. Test results originating from a Clinical Laboratory Improvement Act (CLIA)-certified or similarly accredited laboratory are acceptable; no specific assay is mandated. If there is any question as to whether an EGFR mutation is sensitizing, please contact the primary study team
- Patients that have received prior radiation therapy are eligible. Radiation (whole-brain radiotherapy [WBRT] or stereotactic radiation) must have been completed at least two weeks prior to study registration
- Patient must have measurable disease. Baseline measurements of sites of disease must be obtained within 4 weeks prior to study registration. If a potential target lesion is previously irradiated without subsequent growth and/or is radiated after the imaging from which baseline measurements are obtained, they cannot be included as target lesions, and additional target lesions are required to meet criteria for measurable disease
- Patient must have an Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 2
- All females of childbearing potential must have a blood test or urine study within 14 days prior to registration to rule out pregnancy
- A female of childbearing potential is defined as any woman, regardless of sexual orientation or whether they have undergone tubal ligation, who meets the following criteria: 1) has achieved menarche at some point, 2) has not undergone a hysterectomy or bilateral oophorectomy; or 3) has not been naturally postmenopausal (amenorrhea following cancer therapy does not rule out childbearing potential) for at least 24 consecutive months (i.e., has had menses at any time in the preceding 24 consecutive months)
-
Women of childbearing potential and sexually active males must not expect to conceive or father children by using accepted and effective method(s) of contraception or by abstaining from sexual intercourse for 2 weeks prior to the start of treatment, while on study treatment, and for
- 6 weeks after the last dose of protocol treatment for female patients on the AZD9291 (osimertinib) alone arm
- 4 months after the last dose of protocol treatment for male patients on AZD9291 (osimertinib) alone arm
- 6 months after the last dose of protocol treatment for all patients on AZD9291 (osimertinib) plus bevacizumab combination arm
- NOTE: Female patients should also not breastfeed while on treatment and for 6 months after the last dose bevacizumab
- Leukocytes >= 3,000/mcL (obtained =< 14 days prior to registration)
- Absolute neutrophil count >= 1,500/mcL (obtained =< 14 days prior to registration)
- Platelets >= 100,000/mcL (obtained =< 14 days prior to registration)
- Hemoglobin >= 9 g/dL (obtained =< 14 days prior to registration)
- Total bilirubin and creatinine =< 1.5 x institutional upper limit of normal (ULN) (obtained =< 14 days prior to registration)
- Aspartate aminotransferase (AST) (serum glutamic-oxaloacetic transaminase [SGOT])/alanine aminotransferase (ALT) (serum glutamate pyruvate transaminase [SGPT]) =< 2.5 x institutional ULN (obtained =< 14 days prior to registration)
- Human immunodeficiency virus (HIV)-infected patients on effective anti-retroviral therapy with undetectable viral load within 6 months are eligible for this trial
- For patients with evidence of chronic hepatitis B virus (HBV) infection, the HBV viral load must be undetectable on suppressive therapy, if indicated
- Patients with a history of hepatitis C virus (HCV) infection must have been treated and cured. For patients with HCV infection who are currently on treatment, they are eligible if they have an undetectable HCV viral load
- Patients with treated brain metastases are eligible if neurologically stable without glucocorticoid therapy after the stated washout period from radiation therapy (RT) or surgery provided the metastatic lesions are non-hemorrhagic
- Patients with untreated brain metastases or leptomeningeal disease are eligible if the treating physician determines that immediate CNS specific treatment is not required provided the metastatic lesions are non-hemorrhagic and are neurologically stable without glucocorticoid therapy
- Patients with a prior or concurrent malignancy whose natural history or treatment does not have the potential to interfere with the safety or efficacy assessment of the investigational regimen are eligible for this trial
- Patients with known history or current symptoms of cardiac disease, or history of treatment with cardiotoxic agents, should have a clinical risk assessment of cardiac function using the New York Heart Association Functional Classification. To be eligible for this trial, patients should be class 2B or better
- Patient must have the ability to understand and the willingness to sign a written informed consent document and comply with study requirements
Exclusion Criteria:
- Patient must not have received any prior treatment with an EGFR TKI or with an anti-VEGF agent
- Patient must not have any risk factors for anti-VEGF administration, specifically, hemoptysis, active cardiovascular disease, uncontrolled hypertension, significant proteinuria (screening urine dipstick > 3+) and tumor invading major blood vessels
- Patient must not have had any prior systemic treatment for metastatic disease
- Women must not be pregnant or breast-feeding due to the potential harm to an unborn fetus and possible risk for adverse events in nursing infants with the treatment regimens being used
- Patient must not have had treatment with any investigational drug within five half-lives or 3 months (whichever is greater), prior to study initiation
- Patient must not be currently receiving (or unable to stop use prior to receiving the first dose of study treatment) medications or herbal supplements known to be strong inducers of CYP3A4. For any patient currently receiving such inducers of CYP3A4, they must discontinue use prior to first dose of study treatment. All patients must try to avoid concomitant use of any medications, herbal supplements and/or ingestion of foods with known inducer effects on CYP3A4
- Patient must not have any unresolved toxicities from prior therapy greater than Common Terminology Criteria for Adverse Events (CTCAE) grade 1 at the time of registration, with the exception of alopecia and grade 2 prior platinum-therapy-related neuropathy
- Patient must not have any evidence of severe or uncontrolled systemic diseases, including uncontrolled hypertension and active bleeding diatheses, which in the investigator's opinion makes it challenging for the patient to participate in the study. Screening for chronic conditions is not required
- Patient must not have refractory nausea and vomiting, chronic gastrointestinal diseases, the inability to swallow the osimertinib tablets or previous significant bowel resection that would preclude adequate absorption of osimertinib
- Patient must not have a medical history of interstitial lung disease, drug-induced interstitial lung disease, radiation pneumonitis which required steroid treatment, or any evidence of clinically active interstitial lung disease
- Patient must not have a history of hypersensitivity to active or inactive excipients of osimertinib or drugs with a similar chemical structure or class to osimertinib
- Patient must not have mean resting corrected QT interval (QTc) > 470 msec obtained from 3 electrocardiograms (ECGs), using the screening clinic ECG machine derived QTc value
- Patient must not have any clinically important abnormalities in rhythm, conduction or morphology of resting ECG e.g. complete left bundle branch block, third degree heart block and second-degree heart block
- Patient must not have any factors that increase the risk of QTc prolongation or risk of arrhythmic events such as heart failure, electrolyte abnormalities (including: potassium < lower limit of normal [LLN]; magnesium < LLN; calcium < LLN), congenital long QT syndrome, family history of long QT syndrome or unexplained sudden death under 40 years of age in first degree relatives or any concomitant medication known to prolong the QT interval and cause torsades de pointes

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04181060


United States, Alaska | |
Anchorage Associates in Radiation Medicine | Recruiting |
Anchorage, Alaska, United States, 98508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Anchorage Radiation Therapy Center | Recruiting |
Anchorage, Alaska, United States, 99504 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Alaska Breast Care and Surgery LLC | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Alaska Oncology and Hematology LLC | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Alaska Women's Cancer Care | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Anchorage Oncology Centre | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Katmai Oncology Group | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
Providence Alaska Medical Center | Recruiting |
Anchorage, Alaska, United States, 99508 | |
Contact: Site Public Contact 907-212-6871 AKPAMC.OncologyResearchSupport@providence.org | |
Principal Investigator: Alison K. Conlin | |
United States, Arizona | |
Cancer Center at Saint Joseph's | Recruiting |
Phoenix, Arizona, United States, 85004 | |
Contact: Site Public Contact 602-406-8222 | |
Principal Investigator: Richard L. Deming | |
United States, Arkansas | |
Mercy Hospital Fort Smith | Recruiting |
Fort Smith, Arkansas, United States, 72903 | |
Contact: Site Public Contact 800-378-9373 | |
Principal Investigator: Jay W. Carlson | |
CHI Saint Vincent Cancer Center Hot Springs | Recruiting |
Hot Springs, Arkansas, United States, 71913 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
United States, California | |
Mission Hope Medical Oncology - Arroyo Grande | Recruiting |
Arroyo Grande, California, United States, 93420 | |
Contact: Site Public Contact 916-851-2283 research@dignityhealth.org | |
Principal Investigator: Richard L. Deming | |
Providence Saint Joseph Medical Center/Disney Family Cancer Center | Recruiting |
Burbank, California, United States, 91505 | |
Contact: Site Public Contact 818-847-4793 Najee.Boucher@providence.org | |
Principal Investigator: Alison K. Conlin | |
Washington Hospital | Recruiting |
Fremont, California, United States, 94538 | |
Contact: Site Public Contact 510-745-6433 | |
Principal Investigator: Bogdan S. Eftimie | |
University of California Davis Comprehensive Cancer Center | Recruiting |
Sacramento, California, United States, 95817 | |
Contact: Site Public Contact 916-734-3089 | |
Principal Investigator: Jonathan W. Riess | |
Pacific Central Coast Health Center-San Luis Obispo | Recruiting |
San Luis Obispo, California, United States, 93401 | |
Contact: Site Public Contact Diane.DeVos-Schmidt@DignityHealth.org | |
Principal Investigator: Richard L. Deming | |
Mission Hope Medical Oncology - Santa Maria | Recruiting |
Santa Maria, California, United States, 93444 | |
Contact: Site Public Contact 916-851-2283 research@dignityhealth.org | |
Principal Investigator: Richard L. Deming | |
United States, Colorado | |
Penrose-Saint Francis Healthcare | Recruiting |
Colorado Springs, Colorado, United States, 80907 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Rocky Mountain Cancer Centers-Penrose | Recruiting |
Colorado Springs, Colorado, United States, 80907 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Richard L. Deming | |
Porter Adventist Hospital | Recruiting |
Denver, Colorado, United States, 80210 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Mercy Medical Center | Recruiting |
Durango, Colorado, United States, 81301 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Southwest Oncology PC | Recruiting |
Durango, Colorado, United States, 81301 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Saint Anthony Hospital | Recruiting |
Lakewood, Colorado, United States, 80228 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Littleton Adventist Hospital | Recruiting |
Littleton, Colorado, United States, 80122 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Longmont United Hospital | Recruiting |
Longmont, Colorado, United States, 80501 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Rocky Mountain Cancer Centers-Longmont | Recruiting |
Longmont, Colorado, United States, 80501 | |
Contact: Site Public Contact 303-777-2663 info@westernstatesncorp.org | |
Principal Investigator: Richard L. Deming | |
Parker Adventist Hospital | Recruiting |
Parker, Colorado, United States, 80138 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Saint Mary Corwin Medical Center | Recruiting |
Pueblo, Colorado, United States, 81004 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
United States, Florida | |
Holy Cross Hospital | Recruiting |
Fort Lauderdale, Florida, United States, 33308 | |
Contact: Site Public Contact 954-267-7750 | |
Principal Investigator: Philip J. Stella | |
United States, Georgia | |
Lewis Cancer and Research Pavilion at Saint Joseph's/Candler | Recruiting |
Savannah, Georgia, United States, 31405 | |
Contact: Site Public Contact 912-819-5704 underberga@sjchs.org | |
Principal Investigator: William E. Richards | |
United States, Hawaii | |
Hawaii Cancer Care - Savio | Recruiting |
'Aiea, Hawaii, United States, 96701 | |
Contact: Site Public Contact 808-539-2273 | |
Principal Investigator: Yoshihito Saito | |
Pali Momi Medical Center | Recruiting |
'Aiea, Hawaii, United States, 96701 | |
Contact: Site Public Contact 808-486-6000 | |
Principal Investigator: Yoshihito Saito | |
Queen's Cancer Center - Pearlridge | Recruiting |
'Aiea, Hawaii, United States, 96701 | |
Contact: Site Public Contact 808-487-7447 | |
Principal Investigator: Yoshihito Saito | |
The Cancer Center of Hawaii-Pali Momi | Recruiting |
'Aiea, Hawaii, United States, 96701 | |
Contact: Site Public Contact 808-678-9000 | |
Principal Investigator: Yoshihito Saito | |
Hawaii Cancer Care Inc - Waterfront Plaza | Recruiting |
Honolulu, Hawaii, United States, 96813 | |
Contact: Site Public Contact 808-524-6115 i.webster@hawaiicancercare.com | |
Principal Investigator: Yoshihito Saito | |
Queen's Cancer Cenrer - POB I | Recruiting |
Honolulu, Hawaii, United States, 96813 | |
Contact: Site Public Contact 808-532-0315 | |
Principal Investigator: Yoshihito Saito | |
Queen's Medical Center | Recruiting |
Honolulu, Hawaii, United States, 96813 | |
Contact: Site Public Contact 808-545-8548 | |
Principal Investigator: Yoshihito Saito | |
Straub Clinic and Hospital | Recruiting |
Honolulu, Hawaii, United States, 96813 | |
Contact: Site Public Contact 808-522-4333 | |
Principal Investigator: Yoshihito Saito | |
University of Hawaii Cancer Center | Recruiting |
Honolulu, Hawaii, United States, 96813 | |
Contact: Site Public Contact 808-586-2979 | |
Principal Investigator: Yoshihito Saito | |
Kuakini Medical Center | Recruiting |
Honolulu, Hawaii, United States, 96817 | |
Contact: Site Public Contact 808-547-9816 | |
Principal Investigator: Yoshihito Saito | |
Queen's Cancer Center - Kuakini | Recruiting |
Honolulu, Hawaii, United States, 96817 | |
Contact: Site Public Contact 808-531-8521 | |
Principal Investigator: Yoshihito Saito | |
The Cancer Center of Hawaii-Liliha | Recruiting |
Honolulu, Hawaii, United States, 96817 | |
Contact: Site Public Contact 808-547-6881 | |
Principal Investigator: Yoshihito Saito | |
Kapiolani Medical Center for Women and Children | Recruiting |
Honolulu, Hawaii, United States, 96826 | |
Contact: Site Public Contact 808-983-6090 | |
Principal Investigator: Yoshihito Saito | |
Wilcox Memorial Hospital and Kauai Medical Clinic | Recruiting |
Lihue, Hawaii, United States, 96766 | |
Contact: Site Public Contact 808-535-7960 | |
Principal Investigator: Yoshihito Saito | |
United States, Idaho | |
Saint Alphonsus Cancer Care Center-Boise | Recruiting |
Boise, Idaho, United States, 83706 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Boise | Recruiting |
Boise, Idaho, United States, 83712 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Saint Alphonsus Cancer Care Center-Caldwell | Recruiting |
Caldwell, Idaho, United States, 83605 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Kootenai Medical Center | Recruiting |
Coeur d'Alene, Idaho, United States, 83814 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Walter Knox Memorial Hospital | Recruiting |
Emmett, Idaho, United States, 83617 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Fruitland | Recruiting |
Fruitland, Idaho, United States, 83619 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Idaho Urologic Institute-Meridian | Recruiting |
Meridian, Idaho, United States, 83642 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Meridian | Recruiting |
Meridian, Idaho, United States, 83642 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Saint Alphonsus Medical Center-Nampa | Recruiting |
Nampa, Idaho, United States, 83686 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Nampa | Recruiting |
Nampa, Idaho, United States, 83686 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
Kootenai Cancer Center | Recruiting |
Post Falls, Idaho, United States, 83854 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Kootenai Cancer Clinic | Recruiting |
Sandpoint, Idaho, United States, 83864 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Luke's Cancer Institute - Twin Falls | Recruiting |
Twin Falls, Idaho, United States, 83301 | |
Contact: Site Public Contact 208-381-2774 eslinget@slhs.org | |
Principal Investigator: Alison K. Conlin | |
United States, Illinois | |
Rush - Copley Medical Center | Recruiting |
Aurora, Illinois, United States, 60504 | |
Contact: Site Public Contact 630-978-6212 Cancer.Research@rushcopley.com | |
Principal Investigator: Vamsi K. Vasireddy | |
Illinois CancerCare-Bloomington | Recruiting |
Bloomington, Illinois, United States, 61704 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Canton | Recruiting |
Canton, Illinois, United States, 61520 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Memorial Hospital of Carbondale | Recruiting |
Carbondale, Illinois, United States, 62902 | |
Contact: Site Public Contact 618-457-5200 clinical.research@sih.net | |
Principal Investigator: Bryan A. Faller | |
SIH Cancer Institute | Recruiting |
Carterville, Illinois, United States, 62918 | |
Contact: Site Public Contact 618-985-3333 clinical.research@sih.net | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Carthage | Recruiting |
Carthage, Illinois, United States, 62321 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Centralia Oncology Clinic | Recruiting |
Centralia, Illinois, United States, 62801 | |
Contact: Site Public Contact 217-876-4740 rhamrick@dmhhs.org | |
Principal Investigator: Bryan A. Faller | |
University of Illinois | Recruiting |
Chicago, Illinois, United States, 60612 | |
Contact: Site Public Contact 312-355-3046 | |
Principal Investigator: Sushma Jonna | |
Swedish Covenant Hospital | Recruiting |
Chicago, Illinois, United States, 60625 | |
Contact: Site Public Contact 773-878-8200 | |
Principal Investigator: Elyse A. Lambiase | |
Carle on Vermilion | Recruiting |
Danville, Illinois, United States, 61832 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Vamsi K. Vasireddy | |
Cancer Care Specialists of Illinois - Decatur | Recruiting |
Decatur, Illinois, United States, 62526 | |
Contact: Site Public Contact 217-876-4740 rhamrick@dmhhs.org | |
Principal Investigator: Bryan A. Faller | |
Decatur Memorial Hospital | Recruiting |
Decatur, Illinois, United States, 62526 | |
Contact: Site Public Contact 217-876-4740 rhamrick@dmhhs.org | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Dixon | Recruiting |
Dixon, Illinois, United States, 61021 | |
Contact: Site Public Contact 815-285-7800 | |
Principal Investigator: Bryan A. Faller | |
Carle Physician Group-Effingham | Recruiting |
Effingham, Illinois, United States, 62401 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Vamsi K. Vasireddy | |
Crossroads Cancer Center | Recruiting |
Effingham, Illinois, United States, 62401 | |
Contact: Site Public Contact 217-876-4740 rhamrick@dmhhs.org | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Eureka | Recruiting |
Eureka, Illinois, United States, 61530 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Galesburg | Recruiting |
Galesburg, Illinois, United States, 61401 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Western Illinois Cancer Treatment Center | Recruiting |
Galesburg, Illinois, United States, 61401 | |
Contact: Site Public Contact 309-344-2831 | |
Principal Investigator: Bryan A. Faller | |
Ingalls Memorial Hospital | Recruiting |
Harvey, Illinois, United States, 60426 | |
Contact: Site Public Contact 708-915-4673 clinicaltrials@ingalls.org | |
Principal Investigator: James A. Wallace | |
Illinois CancerCare-Kewanee Clinic | Recruiting |
Kewanee, Illinois, United States, 61443 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Macomb | Recruiting |
Macomb, Illinois, United States, 61455 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Carle Physician Group-Mattoon/Charleston | Recruiting |
Mattoon, Illinois, United States, 61938 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Vamsi K. Vasireddy | |
Good Samaritan Regional Health Center | Recruiting |
Mount Vernon, Illinois, United States, 62864 | |
Contact: Site Public Contact 618-242-4600 | |
Principal Investigator: Jay W. Carlson | |
Cancer Care Center of O'Fallon | Recruiting |
O'Fallon, Illinois, United States, 62269 | |
Contact: Site Public Contact 217-876-4762 morganthaler.jodi@mhsil.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Ottawa Clinic | Recruiting |
Ottawa, Illinois, United States, 61350 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Pekin | Recruiting |
Pekin, Illinois, United States, 61554 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Peoria | Recruiting |
Peoria, Illinois, United States, 61615 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Methodist Medical Center of Illinois | Recruiting |
Peoria, Illinois, United States, 61636 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Peru | Recruiting |
Peru, Illinois, United States, 61354 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Valley Radiation Oncology | Recruiting |
Peru, Illinois, United States, 61354 | |
Contact: Site Public Contact 815-664-4141 | |
Principal Investigator: Bryan A. Faller | |
Illinois CancerCare-Princeton | Recruiting |
Princeton, Illinois, United States, 61356 | |
Contact: Site Public Contact 309-243-3605 andersonj@illinoiscancercare.com | |
Principal Investigator: Bryan A. Faller | |
Southern Illinois University School of Medicine | Recruiting |
Springfield, Illinois, United States, 62702 | |
Contact: Site Public Contact 217-545-7929 | |
Principal Investigator: Bryan A. Faller | |
Springfield Clinic | Recruiting |
Springfield, Illinois, United States, 62702 | |
Contact: Site Public Contact 800-444-7541 | |
Principal Investigator: Bryan A. Faller | |
Memorial Medical Center | Recruiting |
Springfield, Illinois, United States, 62781 | |
Contact: Site Public Contact 217-788-3528 | |
Principal Investigator: Bryan A. Faller | |
Southwest Illinois Health Services LLP | Suspended |
Swansea, Illinois, United States, 62226 | |
Carle Cancer Center | Recruiting |
Urbana, Illinois, United States, 61801 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Vamsi K. Vasireddy | |
The Carle Foundation Hospital | Recruiting |
Urbana, Illinois, United States, 61801 | |
Contact: Site Public Contact 800-446-5532 Research@carle.com | |
Principal Investigator: Vamsi K. Vasireddy | |
Rush-Copley Healthcare Center | Recruiting |
Yorkville, Illinois, United States, 60560 | |
Contact: Site Public Contact 630-978-6212 Cancer.Research@rushcopley.com | |
Principal Investigator: Vamsi K. Vasireddy | |
United States, Iowa | |
Mary Greeley Medical Center | Recruiting |
Ames, Iowa, United States, 50010 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
McFarland Clinic PC - Ames | Recruiting |
Ames, Iowa, United States, 50010 | |
Contact: Site Public Contact 515-239-4734 ksoder@mcfarlandclinic.com | |
Principal Investigator: Debra M. Prow | |
McFarland Clinic PC-Boone | Recruiting |
Boone, Iowa, United States, 50036 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
Medical Oncology and Hematology Associates-West Des Moines | Recruiting |
Clive, Iowa, United States, 50325 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Mercy Cancer Center-West Lakes | Recruiting |
Clive, Iowa, United States, 50325 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Alegent Health Mercy Hospital | Recruiting |
Council Bluffs, Iowa, United States, 51503 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Greater Regional Medical Center | Recruiting |
Creston, Iowa, United States, 50801 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Iowa Methodist Medical Center | Recruiting |
Des Moines, Iowa, United States, 50309 | |
Contact: Site Public Contact 515-241-6727 | |
Principal Investigator: Robert J. Behrens | |
Medical Oncology and Hematology Associates-Des Moines | Recruiting |
Des Moines, Iowa, United States, 50309 | |
Contact: Site Public Contact 515-282-2921 | |
Principal Investigator: Robert J. Behrens | |
Broadlawns Medical Center | Recruiting |
Des Moines, Iowa, United States, 50314 | |
Contact: Site Public Contact 515-282-2200 | |
Principal Investigator: Robert J. Behrens | |
Medical Oncology and Hematology Associates-Laurel | Recruiting |
Des Moines, Iowa, United States, 50314 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Mercy Medical Center - Des Moines | Recruiting |
Des Moines, Iowa, United States, 50314 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Iowa Lutheran Hospital | Recruiting |
Des Moines, Iowa, United States, 50316 | |
Contact: Site Public Contact 515-241-8704 | |
Principal Investigator: Robert J. Behrens | |
McFarland Clinic PC-Trinity Cancer Center | Recruiting |
Fort Dodge, Iowa, United States, 50501 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
Trinity Regional Medical Center | Recruiting |
Fort Dodge, Iowa, United States, 50501 | |
Contact: Site Public Contact 515-574-8302 | |
Principal Investigator: Robert J. Behrens | |
McFarland Clinic PC-Jefferson | Recruiting |
Jefferson, Iowa, United States, 50129 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
McFarland Clinic PC-Marshalltown | Recruiting |
Marshalltown, Iowa, United States, 50158 | |
Contact: Site Public Contact 515-956-4132 | |
Principal Investigator: Debra M. Prow | |
Methodist West Hospital | Recruiting |
West Des Moines, Iowa, United States, 50266-7700 | |
Contact: Site Public Contact 515-343-1000 | |
Principal Investigator: Robert J. Behrens | |
Mercy Medical Center-West Lakes | Recruiting |
West Des Moines, Iowa, United States, 50266 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
United States, Kentucky | |
Flaget Memorial Hospital | Recruiting |
Bardstown, Kentucky, United States, 40004 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Commonwealth Cancer Center-Corbin | Recruiting |
Corbin, Kentucky, United States, 40701 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Saint Joseph Radiation Oncology Resource Center | Recruiting |
Lexington, Kentucky, United States, 40504 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Saint Joseph Hospital East | Recruiting |
Lexington, Kentucky, United States, 40509 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Saint Joseph London | Recruiting |
London, Kentucky, United States, 40741 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Jewish Hospital | Recruiting |
Louisville, Kentucky, United States, 40202 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Saints Mary and Elizabeth Hospital | Recruiting |
Louisville, Kentucky, United States, 40215 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Jewish Hospital Medical Center Northeast | Recruiting |
Louisville, Kentucky, United States, 40245 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Jewish Hospital Medical Center South | Recruiting |
Shepherdsville, Kentucky, United States, 40165 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
United States, Massachusetts | |
Beverly Hospital | Recruiting |
Beverly, Massachusetts, United States, 01915 | |
Contact: Site Public Contact 978-922-3000 ext 2405 | |
Principal Investigator: Paul J. Hesketh | |
Lahey Hospital and Medical Center | Recruiting |
Burlington, Massachusetts, United States, 01805 | |
Contact: Site Public Contact 781-744-3421 cancerclinicaltrials@lahey.org | |
Principal Investigator: Paul J. Hesketh | |
Addison Gilbert Hospital | Recruiting |
Gloucester, Massachusetts, United States, 01930 | |
Contact: Site Public Contact 978-283-4000 ext 559 | |
Principal Investigator: Paul J. Hesketh | |
Lahey Medical Center-Peabody | Recruiting |
Peabody, Massachusetts, United States, 01960 | |
Contact: Site Public Contact 888-823-5923 ctsucontact@westat.com | |
Principal Investigator: Paul J. Hesketh | |
Winchester Hospital | Recruiting |
Winchester, Massachusetts, United States, 01890 | |
Contact: Site Public Contact 888-823-5923 ctsucontact@westat.com | |
Principal Investigator: Paul J. Hesketh | |
UMass Memorial Medical Center - University Campus | Recruiting |
Worcester, Massachusetts, United States, 01655 | |
Contact: Site Public Contact 508-856-3216 cancer.research@umassmed.edu | |
Principal Investigator: William V. Walsh | |
United States, Michigan | |
Hickman Cancer Center | Recruiting |
Adrian, Michigan, United States, 49221 | |
Contact: Site Public Contact 517-265-0116 | |
Principal Investigator: Rex B. Mowat | |
Saint Joseph Mercy Hospital | Recruiting |
Ann Arbor, Michigan, United States, 48106 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
IHA Hematology Oncology Consultants-Brighton | Recruiting |
Brighton, Michigan, United States, 48114 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Saint Joseph Mercy Brighton | Recruiting |
Brighton, Michigan, United States, 48114 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
IHA Hematology Oncology Consultants-Canton | Recruiting |
Canton, Michigan, United States, 48188 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Saint Joseph Mercy Canton | Recruiting |
Canton, Michigan, United States, 48188 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Caro Cancer Center | Recruiting |
Caro, Michigan, United States, 48723 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
IHA Hematology Oncology Consultants-Chelsea | Recruiting |
Chelsea, Michigan, United States, 48118 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Saint Joseph Mercy Chelsea | Recruiting |
Chelsea, Michigan, United States, 48118 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Hematology Oncology Consultants-Clarkston | Recruiting |
Clarkston, Michigan, United States, 48346 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Newland Medical Associates-Clarkston | Recruiting |
Clarkston, Michigan, United States, 48346 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Ascension Saint John Hospital | Recruiting |
Detroit, Michigan, United States, 48236 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Great Lakes Cancer Management Specialists-Doctors Park | Recruiting |
East China Township, Michigan, United States, 48054 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Genesee Cancer and Blood Disease Treatment Center | Recruiting |
Flint, Michigan, United States, 48503 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Genesee Hematology Oncology PC | Recruiting |
Flint, Michigan, United States, 48503 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Genesys Hurley Cancer Institute | Recruiting |
Flint, Michigan, United States, 48503 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Hurley Medical Center | Recruiting |
Flint, Michigan, United States, 48503 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Academic Hematology Oncology Specialists | Recruiting |
Grosse Pointe Woods, Michigan, United States, 48236 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Great Lakes Cancer Management Specialists-Van Elslander Cancer Center | Recruiting |
Grosse Pointe Woods, Michigan, United States, 48236 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Michigan Breast Specialists-Grosse Pointe Woods | Recruiting |
Grosse Pointe Woods, Michigan, United States, 48236 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Sparrow Hospital | Recruiting |
Lansing, Michigan, United States, 48912 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Hope Cancer Clinic | Recruiting |
Livonia, Michigan, United States, 48154 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Saint Mary Mercy Hospital | Recruiting |
Livonia, Michigan, United States, 48154 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Great Lakes Cancer Management Specialists-Macomb Medical Campus | Recruiting |
Macomb, Michigan, United States, 48044 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Michigan Breast Specialists-Macomb Township | Recruiting |
Macomb, Michigan, United States, 48044 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Saint Mary's Oncology/Hematology Associates of Marlette | Recruiting |
Marlette, Michigan, United States, 48453 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Toledo Clinic Cancer Centers-Monroe | Recruiting |
Monroe, Michigan, United States, 48162 | |
Contact: Site Public Contact 800-444-3561 | |
Principal Investigator: Rex B. Mowat | |
21st Century Oncology-Pontiac | Recruiting |
Pontiac, Michigan, United States, 48341 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Hope Cancer Center | Recruiting |
Pontiac, Michigan, United States, 48341 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Newland Medical Associates-Pontiac | Recruiting |
Pontiac, Michigan, United States, 48341 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Saint Joseph Mercy Oakland | Recruiting |
Pontiac, Michigan, United States, 48341 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Great Lakes Cancer Management Specialists-Rochester Hills | Suspended |
Rochester Hills, Michigan, United States, 48309 | |
Ascension Saint Mary's Hospital | Recruiting |
Saginaw, Michigan, United States, 48601 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Oncology Hematology Associates of Saginaw Valley PC | Recruiting |
Saginaw, Michigan, United States, 48604 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Bhadresh Nayak MD PC-Sterling Heights | Recruiting |
Sterling Heights, Michigan, United States, 48312 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Ascension Saint Joseph Hospital | Recruiting |
Tawas City, Michigan, United States, 48764 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Advanced Breast Care Center PLLC | Recruiting |
Warren, Michigan, United States, 48088 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Great Lakes Cancer Management Specialists-Macomb Professional Building | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Macomb Hematology Oncology PC | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Michigan Breast Specialists-Warren | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Saint John Macomb-Oakland Hospital | Recruiting |
Warren, Michigan, United States, 48093 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Saint Mary's Oncology/Hematology Associates of West Branch | Recruiting |
West Branch, Michigan, United States, 48661 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Huron Gastroenterology PC | Recruiting |
Ypsilanti, Michigan, United States, 48106 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
IHA Hematology Oncology Consultants-Ann Arbor | Recruiting |
Ypsilanti, Michigan, United States, 48197 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
United States, Minnesota | |
Sanford Joe Lueken Cancer Center | Recruiting |
Bemidji, Minnesota, United States, 56601 | |
Contact: Site Public Contact 218-333-5000 OncologyClinicalTrialsFargo@sanfordhealth.org | |
Principal Investigator: Preston D. Steen | |
Fairview Ridges Hospital | Recruiting |
Burnsville, Minnesota, United States, 55337 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Minnesota Oncology - Burnsville | Recruiting |
Burnsville, Minnesota, United States, 55337 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Cambridge Medical Center | Recruiting |
Cambridge, Minnesota, United States, 55008 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Mercy Hospital | Recruiting |
Coon Rapids, Minnesota, United States, 55433 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Fairview Southdale Hospital | Recruiting |
Edina, Minnesota, United States, 55435 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Unity Hospital | Recruiting |
Fridley, Minnesota, United States, 55432 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Fairview Clinics and Surgery Center Maple Grove | Recruiting |
Maple Grove, Minnesota, United States, 55369 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Minnesota Oncology Hematology PA-Maplewood | Recruiting |
Maplewood, Minnesota, United States, 55109 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Saint John's Hospital - Healtheast | Recruiting |
Maplewood, Minnesota, United States, 55109 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Abbott-Northwestern Hospital | Recruiting |
Minneapolis, Minnesota, United States, 55407 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Hennepin County Medical Center | Recruiting |
Minneapolis, Minnesota, United States, 55415 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Health Partners Inc | Recruiting |
Minneapolis, Minnesota, United States, 55454 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Monticello Cancer Center | Recruiting |
Monticello, Minnesota, United States, 55362 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
New Ulm Medical Center | Recruiting |
New Ulm, Minnesota, United States, 56073 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Fairview Northland Medical Center | Recruiting |
Princeton, Minnesota, United States, 55371 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
North Memorial Medical Health Center | Recruiting |
Robbinsdale, Minnesota, United States, 55422 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Park Nicollet Clinic - Saint Louis Park | Recruiting |
Saint Louis Park, Minnesota, United States, 55416 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Regions Hospital | Recruiting |
Saint Paul, Minnesota, United States, 55101 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
United Hospital | Recruiting |
Saint Paul, Minnesota, United States, 55102 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Saint Francis Regional Medical Center | Recruiting |
Shakopee, Minnesota, United States, 55379 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Lakeview Hospital | Recruiting |
Stillwater, Minnesota, United States, 55082 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Sanford Thief River Falls Medical Center | Recruiting |
Thief River Falls, Minnesota, United States, 56701 | |
Contact: Site Public Contact 605-312-3320 | |
Principal Investigator: Preston D. Steen | |
Ridgeview Medical Center | Recruiting |
Waconia, Minnesota, United States, 55387 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Rice Memorial Hospital | Recruiting |
Willmar, Minnesota, United States, 56201 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Minnesota Oncology Hematology PA-Woodbury | Recruiting |
Woodbury, Minnesota, United States, 55125 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
Sanford Cancer Center Worthington | Recruiting |
Worthington, Minnesota, United States, 56187 | |
Contact: Site Public Contact 605-312-3320 | |
Principal Investigator: Preston D. Steen | |
Fairview Lakes Medical Center | Recruiting |
Wyoming, Minnesota, United States, 55092 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
United States, Missouri | |
Saint Louis Cancer and Breast Institute-Ballwin | Recruiting |
Ballwin, Missouri, United States, 63011 | |
Contact: Site Public Contact 314-251-7058 | |
Principal Investigator: Jay W. Carlson | |
Saint Francis Medical Center | Recruiting |
Cape Girardeau, Missouri, United States, 63703 | |
Contact: Site Public Contact 573-334-2230 sfmc@sfmc.net | |
Principal Investigator: Bryan A. Faller | |
Southeast Cancer Center | Recruiting |
Cape Girardeau, Missouri, United States, 63703 | |
Contact: Site Public Contact 573-651-5550 | |
Principal Investigator: Bryan A. Faller | |
Parkland Health Center - Farmington | Recruiting |
Farmington, Missouri, United States, 63640 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Capital Region Southwest Campus | Recruiting |
Jefferson City, Missouri, United States, 65109 | |
Contact: Site Public Contact 573-632-4814 swooden@mail.crmc.org | |
Principal Investigator: Bryan A. Faller | |
Freeman Health System | Recruiting |
Joplin, Missouri, United States, 64804 | |
Contact: Site Public Contact 417-347-4030 LJCrockett@freemanhealth.com | |
Principal Investigator: Jay W. Carlson | |
Mercy Hospital Joplin | Recruiting |
Joplin, Missouri, United States, 64804 | |
Contact: Site Public Contact 417-556-3074 esmeralda.carrillo@mercy.net | |
Principal Investigator: Jay W. Carlson | |
Delbert Day Cancer Institute at PCRMC | Recruiting |
Rolla, Missouri, United States, 65401 | |
Contact: Site Public Contact 573-458-8776 kaysmith@phelpshealth.org | |
Principal Investigator: Jay W. Carlson | |
Mercy Clinic-Rolla-Cancer and Hematology | Recruiting |
Rolla, Missouri, United States, 65401 | |
Contact: Site Public Contact 573-458-6379 | |
Principal Investigator: Jay W. Carlson | |
Heartland Regional Medical Center | Recruiting |
Saint Joseph, Missouri, United States, 64506 | |
Contact: Site Public Contact 816-271-7937 linda.schumacher@mymlc.com | |
Principal Investigator: Jay W. Carlson | |
Saint Louis Cancer and Breast Institute-South City | Recruiting |
Saint Louis, Missouri, United States, 63109 | |
Contact: Site Public Contact 314-353-1870 | |
Principal Investigator: Jay W. Carlson | |
Mercy Hospital South | Recruiting |
Saint Louis, Missouri, United States, 63128 | |
Contact: Site Public Contact janet.lesko@mercy.net | |
Principal Investigator: Jay W. Carlson | |
Missouri Baptist Medical Center | Recruiting |
Saint Louis, Missouri, United States, 63131 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Mercy Hospital Saint Louis | Recruiting |
Saint Louis, Missouri, United States, 63141 | |
Contact: Site Public Contact 314-251-7066 | |
Principal Investigator: Jay W. Carlson | |
Sainte Genevieve County Memorial Hospital | Recruiting |
Sainte Genevieve, Missouri, United States, 63670 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Mercy Hospital Springfield | Recruiting |
Springfield, Missouri, United States, 65804 | |
Contact: Site Public Contact 417-269-4520 | |
Principal Investigator: Jay W. Carlson | |
CoxHealth South Hospital | Recruiting |
Springfield, Missouri, United States, 65807 | |
Contact: Site Public Contact 417-269-4520 | |
Principal Investigator: Jay W. Carlson | |
Missouri Baptist Sullivan Hospital | Recruiting |
Sullivan, Missouri, United States, 63080 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Missouri Baptist Outpatient Center-Sunset Hills | Recruiting |
Sunset Hills, Missouri, United States, 63127 | |
Contact: Site Public Contact 314-996-5569 | |
Principal Investigator: Bryan A. Faller | |
Mercy Hospital Washington | Recruiting |
Washington, Missouri, United States, 63090 | |
Contact: Site Public Contact 636-390-1600 | |
Principal Investigator: Jay W. Carlson | |
United States, Montana | |
Community Hospital of Anaconda | Recruiting |
Anaconda, Montana, United States, 59711 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Billings Clinic Cancer Center | Recruiting |
Billings, Montana, United States, 59101 | |
Contact: Site Public Contact 800-996-2663 research@billingsclinic.org | |
Principal Investigator: John M. Schallenkamp | |
Bozeman Deaconess Hospital | Recruiting |
Bozeman, Montana, United States, 59715 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Benefis Healthcare- Sletten Cancer Institute | Recruiting |
Great Falls, Montana, United States, 59405 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Great Falls Clinic | Recruiting |
Great Falls, Montana, United States, 59405 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Kalispell Regional Medical Center | Recruiting |
Kalispell, Montana, United States, 59901 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Patrick Hospital - Community Hospital | Recruiting |
Missoula, Montana, United States, 59802 | |
Contact: Site Public Contact 406-327-3118 amy.hanneman@providence.org | |
Principal Investigator: Alison K. Conlin | |
Community Medical Hospital | Recruiting |
Missoula, Montana, United States, 59804 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp | |
United States, Nebraska | |
CHI Health Saint Francis | Recruiting |
Grand Island, Nebraska, United States, 68803 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
CHI Health Good Samaritan | Recruiting |
Kearney, Nebraska, United States, 68847 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Saint Elizabeth Regional Medical Center | Recruiting |
Lincoln, Nebraska, United States, 68510 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Alegent Health Immanuel Medical Center | Recruiting |
Omaha, Nebraska, United States, 68122 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Alegent Health Bergan Mercy Medical Center | Recruiting |
Omaha, Nebraska, United States, 68124 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Alegent Health Lakeside Hospital | Recruiting |
Omaha, Nebraska, United States, 68130 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Creighton University Medical Center | Recruiting |
Omaha, Nebraska, United States, 68131 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Midlands Community Hospital | Recruiting |
Papillion, Nebraska, United States, 68046 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
United States, New Jersey | |
Rutgers Cancer Institute of New Jersey | Recruiting |
New Brunswick, New Jersey, United States, 08903 | |
Contact: Site Public Contact 732-235-7356 | |
Principal Investigator: Jyoti Malhotra | |
United States, New York | |
Montefiore Medical Center-Einstein Campus | Recruiting |
Bronx, New York, United States, 10461 | |
Contact: Site Public Contact 718-379-6866 eskwak@montefiore.org | |
Principal Investigator: Balazs Halmos | |
Montefiore Medical Center-Weiler Hospital | Recruiting |
Bronx, New York, United States, 10461 | |
Contact: Site Public Contact 718-379-6866 eskwak@montefiore.org | |
Principal Investigator: Balazs Halmos | |
Montefiore Medical Center - Moses Campus | Recruiting |
Bronx, New York, United States, 10467 | |
Contact: Site Public Contact 718-379-6866 eskwak@montefiore.org | |
Principal Investigator: Balazs Halmos | |
Roswell Park Cancer Institute | Not yet recruiting |
Buffalo, New York, United States, 14263 | |
Contact: Site Public Contact 800-767-9355 askroswell@roswellpark.org | |
Principal Investigator: Hongbin Chen | |
Glens Falls Hospital | Recruiting |
Glens Falls, New York, United States, 12801 | |
Contact: Site Public Contact 518-926-6700 | |
Principal Investigator: Aqeel A. Gillani | |
Memorial Sloan Kettering Cancer Center | Recruiting |
New York, New York, United States, 10065 | |
Contact: Site Public Contact 212-639-7592 | |
Principal Investigator: Helena A. Yu | |
Dickstein Cancer Treatment Center | Recruiting |
White Plains, New York, United States, 10601 | |
Contact: Site Public Contact 914-849-7582 mcortese@wphospital.org | |
Principal Investigator: Daniel E. Sammartino | |
United States, North Carolina | |
Southeastern Medical Oncology Center-Clinton | Recruiting |
Clinton, North Carolina, United States, 28328 | |
Contact: Site Public Contact 919-587-9084 jfields@cancersmoc.com | |
Principal Investigator: Samer S. Kasbari | |
Southeastern Medical Oncology Center-Goldsboro | Recruiting |
Goldsboro, North Carolina, United States, 27534 | |
Contact: Site Public Contact 919-587-9084 jfields@cancersmoc.com | |
Principal Investigator: Samer S. Kasbari | |
Southeastern Medical Oncology Center-Jacksonville | Recruiting |
Jacksonville, North Carolina, United States, 28546 | |
Contact: Site Public Contact 910-587-9084 jfields@cancersmoc.com | |
Principal Investigator: Samer S. Kasbari | |
Vidant Oncology-Kenansville | Recruiting |
Kenansville, North Carolina, United States, 28349 | |
Contact: Site Public Contact 252-559-2201 Carla.Zimmerman@vidanthealth.com | |
Principal Investigator: Misbah U. Qadir | |
Vidant Oncology-Kinston | Recruiting |
Kinston, North Carolina, United States, 28501 | |
Contact: Site Public Contact 252-559-2201 Carla.Zimmerman@vidanthealth.com | |
Principal Investigator: Misbah U. Qadir | |
Vidant Oncology-Richlands | Recruiting |
Richlands, North Carolina, United States, 28574 | |
Contact: Site Public Contact 252-559-2201 Carla.Zimmerman@vidanthealth.com | |
Principal Investigator: Misbah U. Qadir | |
United States, North Dakota | |
Sanford Bismarck Medical Center | Recruiting |
Bismarck, North Dakota, United States, 58501 | |
Contact: Site Public Contact 701-323-5760 OncologyClinicalTrialsFargo@sanfordhealth.org | |
Principal Investigator: Preston D. Steen | |
Sanford South University Medical Center | Recruiting |
Fargo, North Dakota, United States, 58103 | |
Contact: Site Public Contact 701-234-6161 | |
Principal Investigator: Preston D. Steen | |
Southpointe-Sanford Medical Center Fargo | Recruiting |
Fargo, North Dakota, United States, 58103 | |
Contact: Site Public Contact 605-312-3320 | |
Principal Investigator: Preston D. Steen | |
Sanford Medical Center Fargo | Recruiting |
Fargo, North Dakota, United States, 58104 | |
Contact: Site Public Contact 800-437-4010 | |
Principal Investigator: Preston D. Steen | |
Sanford Broadway Medical Center | Recruiting |
Fargo, North Dakota, United States, 58122 | |
Contact: Site Public Contact 701-323-5760 OncologyClinicalTrialsFargo@sanfordhealth.org | |
Principal Investigator: Preston D. Steen | |
Sanford Roger Maris Cancer Center | Recruiting |
Fargo, North Dakota, United States, 58122 | |
Contact: Site Public Contact 701-234-6161 OncologyClinicalTrialsFargo@sanfordhealth.org | |
Principal Investigator: Preston D. Steen | |
United States, Ohio | |
UHHS-Chagrin Highlands Medical Center | Recruiting |
Beachwood, Ohio, United States, 44122 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Debora S. Bruno | |
Strecker Cancer Center-Belpre | Recruiting |
Belpre, Ohio, United States, 45714 | |
Contact: Site Public Contact 800-523-3977 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Geauga Hospital | Recruiting |
Chardon, Ohio, United States, 44024 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Debora S. Bruno | |
Adena Regional Medical Center | Recruiting |
Chillicothe, Ohio, United States, 45601 | |
Contact: Site Public Contact 877-779-7585 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
University of Cincinnati/Barrett Cancer Center | Recruiting |
Cincinnati, Ohio, United States, 45219 | |
Contact: Site Public Contact 513-558-4553 uchealthnews@uc.edu | |
Principal Investigator: Muhammad K. Riaz | |
Good Samaritan Hospital - Cincinnati | Recruiting |
Cincinnati, Ohio, United States, 45220 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Bethesda North Hospital | Recruiting |
Cincinnati, Ohio, United States, 45242 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
TriHealth Cancer Institute-Westside | Recruiting |
Cincinnati, Ohio, United States, 45247 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
TriHealth Cancer Institute-Anderson | Recruiting |
Cincinnati, Ohio, United States, 45255 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Case Western Reserve University | Recruiting |
Cleveland, Ohio, United States, 44106 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Debora S. Bruno | |
Cleveland Clinic Foundation | Recruiting |
Cleveland, Ohio, United States, 44195 | |
Contact: Site Public Contact 866-223-8100 TaussigResearch@ccf.org | |
Principal Investigator: Nathan A. Pennell | |
Mount Carmel East Hospital | Recruiting |
Columbus, Ohio, United States, 43213 | |
Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Columbus Oncology and Hematology Associates Inc | Recruiting |
Columbus, Ohio, United States, 43214 | |
Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Riverside Methodist Hospital | Recruiting |
Columbus, Ohio, United States, 43214 | |
Contact: Site Public Contact 614-566-4475 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Grant Medical Center | Recruiting |
Columbus, Ohio, United States, 43215 | |
Contact: Site Public Contact 614-566-4475 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
The Mark H Zangmeister Center | Recruiting |
Columbus, Ohio, United States, 43219 | |
Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Mount Carmel Health Center West | Recruiting |
Columbus, Ohio, United States, 43222 | |
Contact: Site Public Contact 614-234-5433 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Doctors Hospital | Recruiting |
Columbus, Ohio, United States, 43228 | |
Contact: Site Public Contact 614-566-3275 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Delaware Health Center-Grady Cancer Center | Recruiting |
Delaware, Ohio, United States, 43015 | |
Contact: Site Public Contact 740-615-0227 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Grady Memorial Hospital | Recruiting |
Delaware, Ohio, United States, 43015 | |
Contact: Site Public Contact 740-615-2403 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Dublin Methodist Hospital | Recruiting |
Dublin, Ohio, United States, 43016 | |
Contact: Site Public Contact 800-752-9119 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Central Ohio Breast and Endocrine Surgery | Recruiting |
Gahanna, Ohio, United States, 43230 | |
Contact: Site Public Contact 614-488-2745 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Mount Carmel Grove City Hospital | Recruiting |
Grove City, Ohio, United States, 43123 | |
Contact: Site Public Contact 877-779-7585 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Fairfield Medical Center | Recruiting |
Lancaster, Ohio, United States, 43130 | |
Contact: Site Public Contact 740-687-8863 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
OhioHealth Mansfield Hospital | Recruiting |
Mansfield, Ohio, United States, 44903 | |
Contact: Site Public Contact 419-526-8018 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Cleveland Clinic Cancer Center Mansfield | Recruiting |
Mansfield, Ohio, United States, 44906 | |
Contact: Site Public Contact 866-223-8100 TaussigResearch@ccf.org | |
Principal Investigator: Nathan A. Pennell | |
Marietta Memorial Hospital | Recruiting |
Marietta, Ohio, United States, 45750 | |
Contact: Site Public Contact 800-523-3977 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
OhioHealth Marion General Hospital | Recruiting |
Marion, Ohio, United States, 43302 | |
Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Hillcrest Hospital Cancer Center | Recruiting |
Mayfield Heights, Ohio, United States, 44124 | |
Contact: Site Public Contact 866-223-8100 TaussigResearch@ccf.org | |
Principal Investigator: Nathan A. Pennell | |
UH Seidman Cancer Center at Lake Health Mentor Campus | Recruiting |
Mentor, Ohio, United States, 44060 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Debora S. Bruno | |
UH Seidman Cancer Center at Southwest General Hospital | Recruiting |
Middleburg Heights, Ohio, United States, 44130 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Debora S. Bruno | |
Knox Community Hospital | Recruiting |
Mount Vernon, Ohio, United States, 43050 | |
Contact: Site Public Contact 740-393-9000 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Licking Memorial Hospital | Recruiting |
Newark, Ohio, United States, 43055 | |
Contact: Site Public Contact 740-348-4000 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
Newark Radiation Oncology | Recruiting |
Newark, Ohio, United States, 43055 | |
Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
University Hospitals Parma Medical Center | Recruiting |
Parma, Ohio, United States, 44129 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Debora S. Bruno | |
Southern Ohio Medical Center | Recruiting |
Portsmouth, Ohio, United States, 45662 | |
Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
UH Seidman Cancer Center at Firelands Regional Medical Center | Recruiting |
Sandusky, Ohio, United States, 44870 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Debora S. Bruno | |
Mercy Health - Saint Anne Hospital | Recruiting |
Toledo, Ohio, United States, 43623 | |
Contact: Site Public Contact 614-488-2118 sheree@columbusccop.org | |
Principal Investigator: Rex B. Mowat | |
Toledo Clinic Cancer Centers-Toledo | Recruiting |
Toledo, Ohio, United States, 43623 | |
Contact: Site Public Contact 800-444-3561 | |
Principal Investigator: Rex B. Mowat | |
University Hospitals Sharon Health Center | Recruiting |
Wadsworth, Ohio, United States, 44281 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Debora S. Bruno | |
South Pointe Hospital | Recruiting |
Warrensville Heights, Ohio, United States, 44122 | |
Contact: Site Public Contact 866-223-8100 TaussigResearch@ccf.org | |
Principal Investigator: Nathan A. Pennell | |
University Pointe | Recruiting |
West Chester, Ohio, United States, 45069 | |
Contact: Site Public Contact clinicaltrials@ucphysicians.com | |
Principal Investigator: Muhammad K. Riaz | |
Saint Ann's Hospital | Recruiting |
Westerville, Ohio, United States, 43081 | |
Contact: Site Public Contact 614-234-5433 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
UH Seidman Cancer Center at Saint John Medical Center | Recruiting |
Westlake, Ohio, United States, 44145 | |
Contact: Site Public Contact 800-641-2422 CTUReferral@UHhospitals.org | |
Principal Investigator: Debora S. Bruno | |
Genesis Healthcare System Cancer Care Center | Recruiting |
Zanesville, Ohio, United States, 43701 | |
Contact: Site Public Contact 740-454-5232 sheree@columbusccop.org | |
Principal Investigator: Timothy D. Moore | |
United States, Oklahoma | |
University of Oklahoma Health Sciences Center | Recruiting |
Oklahoma City, Oklahoma, United States, 73104 | |
Contact: Site Public Contact 405-271-8777 ou-clinical-trials@ouhsc.edu | |
Principal Investigator: Raid Aljumaily | |
Integris Southwest Medical Center | Recruiting |
Oklahoma City, Oklahoma, United States, 73109 | |
Contact: Site Public Contact 888-823-5923 ctsucontact@westat.com | |
Principal Investigator: Raid Aljumaily | |
Mercy Hospital Oklahoma City | Recruiting |
Oklahoma City, Oklahoma, United States, 73120 | |
Contact: Site Public Contact 405-752-3402 | |
Principal Investigator: Jay W. Carlson | |
Integris Cancer Institute of Oklahoma | Recruiting |
Oklahoma City, Oklahoma, United States, 73142 | |
Contact: Site Public Contact 405-773-6613 | |
Principal Investigator: Raid Aljumaily | |
United States, Oregon | |
Saint Alphonsus Medical Center-Baker City | Recruiting |
Baker City, Oregon, United States, 97814 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Saint Charles Health System | Recruiting |
Bend, Oregon, United States, 97701 | |
Contact: Site Public Contact 541-706-2909 nosall@stcharleshealthcare.org | |
Principal Investigator: Alison K. Conlin | |
Clackamas Radiation Oncology Center | Recruiting |
Clackamas, Oregon, United States, 97015 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Providence Cancer Institute Clackamas Clinic | Recruiting |
Clackamas, Oregon, United States, 97015 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Bay Area Hospital | Recruiting |
Coos Bay, Oregon, United States, 97420 | |
Contact: Site Public Contact 541-269-8392 cherie.cox@bayareahospital.org | |
Principal Investigator: Alison K. Conlin | |
Providence Newberg Medical Center | Recruiting |
Newberg, Oregon, United States, 97132 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Saint Alphonsus Medical Center-Ontario | Recruiting |
Ontario, Oregon, United States, 97914 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: John M. Schallenkamp | |
Providence Portland Medical Center | Recruiting |
Portland, Oregon, United States, 97213 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Providence Saint Vincent Medical Center | Recruiting |
Portland, Oregon, United States, 97225 | |
Contact: Site Public Contact 503-215-2614 CanRsrchStudies@providence.org | |
Principal Investigator: Alison K. Conlin | |
Saint Charles Health System-Redmond | Recruiting |
Redmond, Oregon, United States, 97756 | |
Contact: Site Public Contact 541-706-2909 | |
Principal Investigator: Alison K. Conlin | |
United States, Pennsylvania | |
Lehigh Valley Hospital-Cedar Crest | Recruiting |
Allentown, Pennsylvania, United States, 18103 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Lehigh Valley Hospital - Muhlenberg | Recruiting |
Bethlehem, Pennsylvania, United States, 18017 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Bryn Mawr Hospital | Recruiting |
Bryn Mawr, Pennsylvania, United States, 19010 | |
Contact: Site Public Contact 484-476-2649 turzoe@mlhs.org | |
Principal Investigator: Albert S. DeNittis | |
Main Line Health Center-Collegeville | Recruiting |
Collegeville, Pennsylvania, United States, 19426 | |
Contact: Site Public Contact 484-476-2649 turzoe@mlhs.org | |
Principal Investigator: Albert S. DeNittis | |
Pocono Medical Center | Recruiting |
East Stroudsburg, Pennsylvania, United States, 18301 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Main Line Health Center-Exton | Recruiting |
Exton, Pennsylvania, United States, 19341 | |
Contact: Site Public Contact 484-476-2649 turzoe@mlhs.org | |
Principal Investigator: Albert S. DeNittis | |
Lehigh Valley Hospital-Hazleton | Recruiting |
Hazleton, Pennsylvania, United States, 18201 | |
Contact: Site Public Contact 734-712-3671 stephanie.couch@stjoeshealth.org | |
Principal Investigator: Philip J. Stella | |
Riddle Memorial Hospital | Recruiting |
Media, Pennsylvania, United States, 19063 | |
Contact: Site Public Contact 484-476-2649 turzoe@mlhs.org | |
Principal Investigator: Albert S. DeNittis | |
Paoli Memorial Hospital | Recruiting |
Paoli, Pennsylvania, United States, 19301 | |
Contact: Site Public Contact 484-476-2649 turzoe@mlhs.org | |
Principal Investigator: Albert S. DeNittis | |
Fox Chase Cancer Center | Recruiting |
Philadelphia, Pennsylvania, United States, 19111 | |
Contact: Site Public Contact 215-728-4790 | |
Principal Investigator: Jessica R. Bauman | |
Lankenau Medical Center | Recruiting |
Wynnewood, Pennsylvania, United States, 19096 | |
Contact: Site Public Contact 484-476-2649 turzoe@mlhs.org | |
Principal Investigator: Albert S. DeNittis | |
United States, South Dakota | |
Sanford Cancer Center Oncology Clinic | Recruiting |
Sioux Falls, South Dakota, United States, 57104 | |
Contact: Site Public Contact 605-312-3320 OncologyClinicTrialsSF@sanfordhealth.org | |
Principal Investigator: Preston D. Steen | |
Sanford USD Medical Center - Sioux Falls | Recruiting |
Sioux Falls, South Dakota, United States, 57117-5134 | |
Contact: Site Public Contact 605-312-3320 OncologyClinicalTrialsSF@SanfordHealth.org | |
Principal Investigator: Preston D. Steen | |
United States, Tennessee | |
Vanderbilt University/Ingram Cancer Center | Recruiting |
Nashville, Tennessee, United States, 37232 | |
Contact: Site Public Contact 800-811-8480 | |
Principal Investigator: Christine M. Lovly | |
United States, Texas | |
Saint Joseph Regional Cancer Center | Recruiting |
Bryan, Texas, United States, 77802 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
United States, Washington | |
Providence Regional Cancer System-Aberdeen | Recruiting |
Aberdeen, Washington, United States, 98520 | |
Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
Principal Investigator: Alison K. Conlin | |
PeaceHealth Saint Joseph Medical Center | Recruiting |
Bellingham, Washington, United States, 98225 | |
Contact: Site Public Contact 360-788-8238 lkey@peacehealth.org | |
Principal Investigator: Alison K. Conlin | |
Harrison HealthPartners Hematology and Oncology-Bremerton | Recruiting |
Bremerton, Washington, United States, 98310 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Harrison Medical Center | Recruiting |
Bremerton, Washington, United States, 98310 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Highline Medical Center-Main Campus | Recruiting |
Burien, Washington, United States, 98166 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Providence Regional Cancer System-Centralia | Recruiting |
Centralia, Washington, United States, 98531 | |
Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
Principal Investigator: Alison K. Conlin | |
Swedish Cancer Institute-Edmonds | Recruiting |
Edmonds, Washington, United States, 98026 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
Saint Elizabeth Hospital | Recruiting |
Enumclaw, Washington, United States, 98022 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Providence Regional Cancer Partnership | Recruiting |
Everett, Washington, United States, 98201 | |
Contact: Site Public Contact 425-261-3529 marilyn.birchman@providence.org | |
Principal Investigator: Alison K. Conlin | |
Saint Francis Hospital | Recruiting |
Federal Way, Washington, United States, 98003 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Swedish Cancer Institute-Issaquah | Recruiting |
Issaquah, Washington, United States, 98029 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
Kadlec Clinic Hematology and Oncology | Recruiting |
Kennewick, Washington, United States, 99336 | |
Contact: Site Public Contact 509-783-4637 research@kadlecmed.org | |
Principal Investigator: Alison K. Conlin | |
Providence Regional Cancer System-Lacey | Recruiting |
Lacey, Washington, United States, 98503 | |
Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
Principal Investigator: Alison K. Conlin | |
Saint Clare Hospital | Recruiting |
Lakewood, Washington, United States, 98499 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
PeaceHealth Saint John Medical Center | Recruiting |
Longview, Washington, United States, 98632 | |
Contact: Site Public Contact 360-514-2016 kmakin-bond@peacehealth.org | |
Principal Investigator: Alison K. Conlin | |
Harrison HealthPartners Hematology and Oncology-Poulsbo | Recruiting |
Poulsbo, Washington, United States, 98370 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Pacific Gynecology Specialists | Recruiting |
Seattle, Washington, United States, 98104 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
Swedish Medical Center-Ballard Campus | Recruiting |
Seattle, Washington, United States, 98107 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
Swedish Medical Center-First Hill | Recruiting |
Seattle, Washington, United States, 98122-4307 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
Swedish Medical Center-Cherry Hill | Recruiting |
Seattle, Washington, United States, 98122-5711 | |
Contact: Site Public Contact 206-215-3086 PCRC-NCORP@Swedish.org | |
Principal Investigator: Alison K. Conlin | |
PeaceHealth United General Medical Center | Recruiting |
Sedro-Woolley, Washington, United States, 98284 | |
Contact: Site Public Contact 360-788-8238 lkey@peacehealth.org | |
Principal Investigator: Alison K. Conlin | |
Providence Regional Cancer System-Shelton | Recruiting |
Shelton, Washington, United States, 98584 | |
Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
Principal Investigator: Alison K. Conlin | |
Franciscan Research Center-Northwest Medical Plaza | Recruiting |
Tacoma, Washington, United States, 98405 | |
Contact: Site Public Contact 308-398-6518 clinicaltrials@sfmc-gi.org | |
Principal Investigator: Richard L. Deming | |
Northwest Medical Specialties PLLC | Recruiting |
Tacoma, Washington, United States, 98405 | |
Contact: Site Public Contact 253-306-0532 research@southsoundcare.org | |
Principal Investigator: Richard L. Deming | |
PeaceHealth Southwest Medical Center | Recruiting |
Vancouver, Washington, United States, 98664 | |
Contact: Site Public Contact 360-514-3940 kmakin-bond@peacehealth.org | |
Principal Investigator: Alison K. Conlin | |
Providence Saint Mary Regional Cancer Center | Recruiting |
Walla Walla, Washington, United States, 99362 | |
Contact: Site Public Contact 509-897-5993 Cheryl.Dodd@providence.org | |
Principal Investigator: Alison K. Conlin | |
Providence Regional Cancer System-Yelm | Recruiting |
Yelm, Washington, United States, 98597 | |
Contact: Site Public Contact 360-412-8958 deidre.dillon@providence.org | |
Principal Investigator: Alison K. Conlin | |
United States, Wisconsin | |
Gundersen Lutheran Medical Center | Recruiting |
La Crosse, Wisconsin, United States, 54601 | |
Contact: Site Public Contact 608-775-2385 cancerctr@gundersenhealth.org | |
Principal Investigator: Kurt Oettel | |
ProHealth D N Greenwald Center | Recruiting |
Mukwonago, Wisconsin, United States, 53149 | |
Contact: Site Public Contact research.institute@phci.org | |
Principal Investigator: Timothy R. Wassenaar | |
Cancer Center of Western Wisconsin | Recruiting |
New Richmond, Wisconsin, United States, 54017 | |
Contact: Site Public Contact 952-993-1517 mmcorc@healthpartners.com | |
Principal Investigator: David M. King | |
ProHealth Oconomowoc Memorial Hospital | Recruiting |
Oconomowoc, Wisconsin, United States, 53066 | |
Contact: Site Public Contact 262-928-7878 | |
Principal Investigator: Timothy R. Wassenaar | |
ProHealth Waukesha Memorial Hospital | Recruiting |
Waukesha, Wisconsin, United States, 53188 | |
Contact: Site Public Contact 262-928-7632 | |
Principal Investigator: Timothy R. Wassenaar | |
UW Cancer Center at ProHealth Care | Recruiting |
Waukesha, Wisconsin, United States, 53188 | |
Contact: Site Public Contact 262-928-5539 Chanda.miller@phci.org | |
Principal Investigator: Timothy R. Wassenaar | |
United States, Wyoming | |
Billings Clinic-Cody | Recruiting |
Cody, Wyoming, United States, 82414 | |
Contact: Site Public Contact 800-996-2663 research@billingsclinic.org | |
Principal Investigator: John M. Schallenkamp | |
Welch Cancer Center | Recruiting |
Sheridan, Wyoming, United States, 82801 | |
Contact: Site Public Contact 406-969-6060 mccinfo@mtcancer.org | |
Principal Investigator: John M. Schallenkamp |
Principal Investigator: | Helena A Yu | ECOG-ACRIN Cancer Research Group |
Responsible Party: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT04181060 |
Other Study ID Numbers: |
NCI-2019-07941 NCI-2019-07941 ( Registry Identifier: CTRP (Clinical Trial Reporting Program) ) EA5182 ( Other Identifier: ECOG-ACRIN Cancer Research Group ) EA5182 ( Other Identifier: CTEP ) U10CA180820 ( U.S. NIH Grant/Contract ) |
First Posted: | November 29, 2019 Key Record Dates |
Last Update Posted: | February 21, 2021 |
Last Verified: | January 2021 |
Individual Participant Data (IPD) Sharing Statement: | |
Plan to Share IPD: | Yes |
Plan Description: | NCI is committed to sharing data in accordance with NIH policy. For more details on how clinical trial data is shared, access the link to the NIH data sharing policy page. |
URL: | https://grants.nih.gov/policy/sharing.htm |
Studies a U.S. FDA-regulated Drug Product: | Yes |
Studies a U.S. FDA-regulated Device Product: | No |
Carcinoma Lung Neoplasms Carcinoma, Non-Small-Cell Lung Neoplasms, Glandular and Epithelial Neoplasms by Histologic Type Neoplasms Respiratory Tract Neoplasms Thoracic Neoplasms Neoplasms by Site Lung Diseases Respiratory Tract Diseases Carcinoma, Bronchogenic Bronchial Neoplasms Bevacizumab Antineoplastic Agents, Immunological |
Osimertinib Endothelial Growth Factors Antibodies Immunoglobulins Antibodies, Monoclonal Immunoglobulin G Antineoplastic Agents Angiogenesis Inhibitors Angiogenesis Modulating Agents Growth Substances Physiological Effects of Drugs Growth Inhibitors Immunologic Factors Molecular Mechanisms of Pharmacological Action Protein Kinase Inhibitors |